SAN DIEGO, Nov. 11, 2024 /PRNewswire/ -- Neurelis, Inc., today announced a presentation on insights into study design from the enrollment process for the new Stellina study investigating VALTOCO® ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback